Nevro Corp. NVRO
Trading inactive
Analyst Consensus
Price Objectif
Analyst historical
| Analyste | Entreprise | Prix lors de l'analyse | Prix cible | Gain potentiel | Date de publication |
|---|---|---|---|---|---|
| Kallum Titchmarsh | Morgan Stanley | 4.44 $ | 4 $ | -0.44 % | 02/12/2024 |
| David Rescott | Robert W. Baird | 4.92 $ | 5 $ | 0.08 % | 15/10/2024 |
| Joanna Wuensch | Citigroup | 5.67 $ | 6.89 $ | 1.22 % | 08/08/2024 |
| Richard Newitter | Truist Financial | 5.08 $ | 5.5 $ | 0.42 % | 08/08/2024 |
| David Rescott | Robert W. Baird | 5 $ | 8 $ | 3.00 % | 07/08/2024 |
| Matthew Taylor | Jefferies | 4.83 $ | 7 $ | 2.17 % | 07/08/2024 |
| Adam Maeder | Piper Sandler | 8.69 $ | 7 $ | -1.69 % | 07/08/2024 |
| Nathan Treybeck | Wells Fargo | 8.69 $ | 5.5 $ | -3.19 % | 07/08/2024 |
| Anthony Petrone | Mizuho Securities | 13.28 $ | 16 $ | 2.72 % | 11/04/2024 |
| Nathan Treybeck | Wells Fargo | 13.29 $ | 14 $ | 0.71 % | 08/04/2024 |
| Suraj Kalia | Oppenheimer | 23.7084 $ | 40 $ | 16.29 % | 06/06/2023 |
| Canaccord Canaccord | Canaccord Genuity | 40.19 $ | 67 $ | 26.81 % | 25/12/2022 |
| David Turkaly | JMP Securities | 70.96 $ | 125 $ | 54.04 % | 24/02/2022 |
| Robbie Marcus | J.P. Morgan | 70.96 $ | 70 $ | -0.96 % | 24/02/2022 |
| Joanne Wuensch | Citigroup | 82.13 $ | 94 $ | 11.87 % | 15/12/2021 |